Prokidney (PROK) Capital Expenditures (2021 - 2026)

Prokidney (PROK) has 6 years of Capital Expenditures data on file, last reported at $3.8 million in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $3.8 million, up 233.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.8 million (down 39.88% YoY), and the FY2025 annual result was $15.2 million, down 48.5% from the prior year.
• Capital Expenditures retreated to $3.8 million in Q1 2026 per PROK's latest filing, from $5.8 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $27.9 million in Q3 2023 and troughed at $306000.0 in Q4 2022.
• A 5-year average of $5.0 million and a median of $1.6 million in 2023 frame the typical range for Capital Expenditures.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures soared 8769.52% in 2023, then sank 91.4% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $306000.0 in 2022, then jumped by 413.73% to $1.6 million in 2023, then soared by 1522.71% to $25.5 million in 2024, then slumped by 77.45% to $5.8 million in 2025, then plunged by 34.2% to $3.8 million in 2026.
• Business Quant data shows PROK's Capital Expenditures at $3.8 million in Q1 2026, $5.8 million in Q4 2025, and $5.2 million in Q3 2025.